Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DASA3.SA
HoldDiagnósticos da América S.A. · Healthcare · Brazil · $636M · Avg Vol: $595K/d
59
StockRankGet insider-trade alerts
Q
47
V
71
M
35
P/E (TTM)
—
ROE
-12.1%
D/E
1.1x
Dividend %
—
COMPANY DESCRIPTION
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.1B | 14.3B | 15.3B | 11.2B | -5.2% | 9.4B | 8.9B | 9.8B | -6.4% |
| EPS (BRL) | -0.31 | -1.56 | -0.96 | -0.92 | — | -0.72 | — | — | — |
| Shares | 1.2B | 747.0M | 1.2B | 1.2B | -0.0% | 1.2B | — | — | — |
| Debt | 13.9B | 13.3B | 13.0B | 8.8B | -14.0% | 7.8B | — | — | — |
| Equity | 7.1B | 7.3B | 7.9B | 6.9B | -1.0% | — | — | — | — |
| Op CF | -29.0M | -963.6M | 27.9M | -36.3M | — | 440.5M | — | — | — |
| Inv CF | -1.6B | 979.0M | -373.6M | 1.4B | — | — | — | — | — |
| Fin CF | 1.8B | 284.9M | 503.2M | -393.0M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-12.9%
SMA 50SMA 200
Close
$0.4803
RSI (14)
38.6
52W High
$0.9164
From 52W High
0.5%
SCORE BREAKDOWN
Quality
47
ROIC
6.3%61.8
ROE
-12.1%35.4
GP/Assets
15.6%36.8
Op. Margin
10.8%66.5
FCF/Assets
2.6%58.4
Piotroski
376.5
Int. Cover
0.6x40.0
D/E Ratio
1.12x12.6
Current Ratio
1.27x19.2
Value
71
P/E (TTM)
—N/A
EV/EBITDA
6.8x85.2
P/FCF
6.7x90.0
P/B
0.5x97.5
P/S
0.3x95.3
Div Yield
—N/A
Momentum
35
52W High %
52%25.6
RS 6M
-31%30.8
SMA 50/200
0.82x21.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+132%81.2
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$636M
P/E (Forward)
11.5x
Gross Margin
31.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DASA3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DASA3.SA | Diagnósticos da América S.A.(you) | $636M | 59 | Hold |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| BIOM3.SA | Biomm S.A. | $180M | 43 | Hold |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| RADL3.SA | Raia Drogasil S.A. | $6.7B | 64 | Hold |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 98 | Strong Buy |
Peer medians: ROE 10.6% · P/E 12.8x · Gross margin 30.3%